Main Sequence Ventures: Venture capital investment and company building expertise

Opportunity for

• Researchers, innovators, and inventors developing ideas that could become globally significant companies.
  ^This opportunity is only for professional and sophisticated investors.

Opportunity description

Industry challenge:

Food production must double to feed 10 billion people by 2050. Sweeping changes to farming and how we produce food are required; technology and science hold the key.

Current opportunity:

"Feed 10b People" is an important challenge area in Main Sequence. As Asia Pacific's biggest deep tech venture firm, founded by CSIRO, we help by fueling inventors' ideas with capital and support.

Main Sequence welcomes approaches from researchers, innovators, and inventors developing ideas that could become globally significant companies.

Opportunity background:

Main Sequence Ventures Innovation Fund was created by CSIRO to address the ‘valley of death’ between research and commercialisation.

Main Sequence’s origins within CSIRO reflect its commitment to amplifying connections between industry, research and infrastructure to accelerate deep technology development, and reinvesting economic returns from commercialisation back into science.

CSIRO Innovation Funds 1 and 2 managed by Main Sequence, have invested in 4 companies since establishment in 2017. These companies have created over 1,200 jobs by working with partners in industry, CSIRO, and 22 Australian universities.

Main Sequence 'Feed 10b People' Portfolio companies include Eden Brew, Every, Lumachain, Nourish Ingredients, RapidAIM, regrow and v2food.

Other areas of interest:

Advanced materials that come from food production systems. Open to collaborate with other investors.